The client is a leading biotechnology company focused on developing and producing biosimilars. The company contributes to the future of biotechnology through innovation and quality.

The client had planned to build a biotechnology laboratory for the production of recombinant mammalian cell proteins in large scale, however the company never moved forward with the project. This left the client with a surplus of new, uninstalled assets that were no longer needed. The main priority for this disposition plan is to maximize returns for the client.

This is an ongoing project and equipment to be sold features a range of biopharmaceutical lab equipment, including chromatography columns, shakers, air handlers, tanks, steam generators, centrifuges, water chillers, FPLCs, homogenizers, and much more.

EquipNet’s specialists provided an onsite inventory of the equipment. To ensure maximum return, EquipNet listed the assets onto its online MarketPlace for negotiated sale.

•Project Management                   •Individual Asset Sales
•Onsite Inventory                           •Worldwide Logistics

The client’s original expectation was to generate $500,000 in sales within four months. To date, we have helped the client achieve almost $700,000 in return, with remaining assets valued at a minimum of $1.2 million.